Great to share our team’s work at GCOM - qMRI, amyloid PET, and IBM genetics, plus invited talks on CAR‑T therapy and environmental factors in myositis. Proud of the team and collaborators, and excited about what this means for improving care for patients. @uclqsneuromuscular.bsky.social

First-ever classification criteria for #haemochromatosis arthropathy now published! A major step for research & trials in this under-recognised condition. Thanks to the @eular.org task force who made this possible - a privilege to work together since 2020! www.sciencedirect.com/science/arti...

✨️MIHRA Membership✨️ is cost-free and strives for diverse and global inclusion. If you haven’t already registered for MIHRA membership, you are welcome to either follow the QR below or click this link for the MIHRA membership form: forms.gle/HmYbFxtPZFFu27… which takes about 5 minutes!

UCL Queen Square Institute of Neurology Summer Drinks, October Gallery, July 2025 ☺️

Great talk by @nathan-routledge.bsky.social from @uclqsneuromuscular.bsky.social on his Myositis UK-funded PhD: exploring disease pathways for IBM stratification and therapy. Delighted to be at the Myositis UK charity annual meeting, an event I’ve proudly contributed to for over a decade! #Myositis

Excellent talk @pedrommcmachado.bsky.social identifying predicted sig increase in RMDs in the coming years! #EULAR2025